Should we recommend SGLT2i initiation at discharge to all patients hospitalized with acute myocardial infarction?
2
1 Answers
Mednet Member
Endocrinology · Duke Endocrinology Clinic
The strict answer to this question, including "all patients hospitalized with acute MI" is no based on the results of the recently reported EMPACT-MI trial. In this study of more than 6000 patients empagliflozin did not significantly improve a composite endpoint of hospitalization for heart failure ...